AN69ST membranes adsorb nafamostat mesylate and affect the management of anticoagulant therapy: a retrospective study

BACKGROUND: In Japan, nafamostat mesylate (NM) is frequently used as an anticoagulant during continuous renal replacement therapy (CRRT). The dialyzer membrane AN69ST has been reported to adsorb NM and affect the management of anticoagulant therapy. However, the adsorbed amount has not yet been quan...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Intensive Care
Autori principali: Hirayama, Takahiro, Nosaka, Nobuyuki, Okawa, Yasumasa, Ushio, Soichiro, Kitamura, Yoshihisa, Sendo, Toshiaki, Ugawa, Toyomu, Nakao, Atsunori
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5516335/
https://ncbi.nlm.nih.gov/pubmed/28729905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-017-0244-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi